Skornova Ingrid, Simurda Tomas, Stanciakova Lucia, Lauko Viliam, Holly Pavol, Samos Matej, Bolek Tomas, Schnierer Martin, Drotarova Miroslava, Belakova Kristina Maria, Sokol Juraj, Stasko Jan, Mokan Marian, Gumulec Jaroslav, Chrastinova Leona
National Center of Hemostasis and Thrombosis, Department of Hematology and Transfusiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin and University Hospital in Martin, 03601 Martin, Slovakia.
National Institute of Cardiovascular Diseases, 83348 Bratislava, Slovakia.
Diagnostics (Basel). 2023 Sep 21;13(18):3019. doi: 10.3390/diagnostics13183019.
Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy (both unfractionated heparin and low-molecular-weight heparin). In our study, we examined a group of 122 patients with suspected HIT. The samples of all patients were analyzed in the first step using an immunoassay (ID-PaGIA Heparin/PF4, Hemos1L-Acustar HIT IgG, ZYMUTEST HIA Monostrip IgG) to detect the presence of antibodies against heparin-PF4 complexes (platelet factor 4). When the immunoassay was positive, the sample was subsequently analyzed for HIT with a functional flow cytometry assay, the HITAlert kit, the purpose of which was to demonstrate the ability of the antibodies present to activate platelets. A diagnosis of HIT can be made only after a positive functional test result. In this article, we present an overview of our practical experience with the use of the new functional method of analysis, HIT, with flow cytometry. In this work, we compared the mutual sensitivity of two functional tests, SRA and the flow cytometry HITAlert kit, in patients perceived as being at risk for HIT. This work aims to delineate the principle, procedure, advantages, pitfalls, and possibilities of the application of the functional test HITAlert using flow cytometry.
肝素诱导的血小板减少症(HIT)是肝素治疗(包括普通肝素和低分子肝素)的一种危及生命的并发症。在我们的研究中,我们检查了一组122例疑似HIT的患者。第一步,使用免疫测定法(ID-PaGIA肝素/PF4、Hemos1L-Acustar HIT IgG、ZYMUTEST HIA Monostrip IgG)对所有患者的样本进行分析,以检测抗肝素-PF4复合物(血小板因子4)抗体的存在。当免疫测定呈阳性时,随后使用功能性流式细胞术检测试剂盒HITAlert对样本进行HIT分析,其目的是证明存在的抗体激活血小板的能力。只有在功能性检测结果为阳性后才能做出HIT诊断。在本文中,我们概述了使用新型功能性分析方法(流式细胞术检测HIT)的实际经验。在这项工作中,我们比较了两种功能性检测方法(SRA和流式细胞术HITAlert试剂盒)在被认为有HIT风险的患者中的相互敏感性。这项工作旨在阐述使用流式细胞术进行功能性检测HITAlert的原理、程序、优点、缺陷及应用可能性。